# A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021

> **NCT01498497** · — · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 14 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** EUR-1100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01498497
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01498497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01498497, "A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01498497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*